First Time Loading...

Suzuken Co Ltd
TSE:9987

Watchlist Manager
Suzuken Co Ltd Logo
Suzuken Co Ltd
TSE:9987
Watchlist
Price: 4 624 JPY +0.85% Market Closed
Updated: Oct 1, 2023

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Suzuken Co Ltd

Revenue
2.3T JPY
Cost of Revenue
-2.2T JPY
Gross Profit
181B JPY
Operating Expenses
-148.3B JPY
Operating Income
33.1B JPY
Other Expenses
-12.1B JPY
Net Income
21B JPY

Margins Comparison
Suzuken Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
JP
Suzuken Co Ltd
TSE:9987
383B JPY
8%
1%
1%
US
Mckesson Corp
NYSE:MCK
58.7B USD
4%
2%
1%
US
Amerisourcebergen Corp
NYSE:ABC
37B USD
3%
1%
1%
US
Cencora Inc
XBER:ABG
34.4B EUR N/A N/A N/A
US
Cardinal Health Inc
NYSE:CAH
21.8B USD
3%
1%
0%
CN
Huadong Medicine Co Ltd
SZSE:000963
73.9B CNY
31%
9%
7%
US
Henry Schein Inc
NASDAQ:HSIC
9.7B USD
30%
7%
4%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
66.9B CNY
13%
4%
2%
CN
Sinopharm Group Co Ltd
HKEX:1099
70.1B HKD
9%
4%
2%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
10.1T KRW
28%
12%
7%
IT
Amplifon SpA
MIL:AMP
6.4B EUR
58%
13%
8%
Country JP
Market Cap 383B JPY
Gross Margin
8%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 58.7B USD
Gross Margin
4%
Operating Margin
2%
Net Margin
1%
Country US
Market Cap 37B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 34.4B EUR
Gross Margin N/A
Operating Margin N/A
Net Margin N/A
Country US
Market Cap 21.8B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
0%
Country CN
Market Cap 73.9B CNY
Gross Margin
31%
Operating Margin
9%
Net Margin
7%
Country US
Market Cap 9.7B USD
Gross Margin
30%
Operating Margin
7%
Net Margin
4%
Country CN
Market Cap 66.9B CNY
Gross Margin
13%
Operating Margin
4%
Net Margin
2%
Country CN
Market Cap 70.1B HKD
Gross Margin
9%
Operating Margin
4%
Net Margin
2%
Country KR
Market Cap 10.1T KRW
Gross Margin
28%
Operating Margin
12%
Net Margin
7%
Country IT
Market Cap 6.4B EUR
Gross Margin
58%
Operating Margin
13%
Net Margin
8%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Suzuken Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
JP
Suzuken Co Ltd
TSE:9987
383B JPY
5%
2%
7%
8%
US
Mckesson Corp
NYSE:MCK
58.7B USD
-172%
6%
32%
20%
US
Amerisourcebergen Corp
NYSE:ABC
37B USD
371%
3%
18%
13%
US
Cencora Inc
XBER:ABG
34.4B EUR N/A N/A N/A N/A
US
Cardinal Health Inc
NYSE:CAH
21.8B USD
-15%
1%
15%
7%
CN
Huadong Medicine Co Ltd
SZSE:000963
73.9B CNY
14%
8%
17%
13%
US
Henry Schein Inc
NASDAQ:HSIC
9.7B USD
16%
6%
14%
9%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
66.9B CNY
10%
3%
10%
6%
CN
Sinopharm Group Co Ltd
HKEX:1099
70.1B HKD
13%
2%
18%
10%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
10.1T KRW
7%
4%
10%
6%
IT
Amplifon SpA
MIL:AMP
6.4B EUR
18%
5%
11%
7%
Country JP
Market Cap 383B JPY
ROE
5%
ROA
2%
ROCE
7%
ROIC
8%
Country US
Market Cap 58.7B USD
ROE
-172%
ROA
6%
ROCE
32%
ROIC
20%
Country US
Market Cap 37B USD
ROE
371%
ROA
3%
ROCE
18%
ROIC
13%
Country US
Market Cap 34.4B EUR
ROE N/A
ROA N/A
ROCE N/A
ROIC N/A
Country US
Market Cap 21.8B USD
ROE
-15%
ROA
1%
ROCE
15%
ROIC
7%
Country CN
Market Cap 73.9B CNY
ROE
14%
ROA
8%
ROCE
17%
ROIC
13%
Country US
Market Cap 9.7B USD
ROE
16%
ROA
6%
ROCE
14%
ROIC
9%
Country CN
Market Cap 66.9B CNY
ROE
10%
ROA
3%
ROCE
10%
ROIC
6%
Country CN
Market Cap 70.1B HKD
ROE
13%
ROA
2%
ROCE
18%
ROIC
10%
Country KR
Market Cap 10.1T KRW
ROE
7%
ROA
4%
ROCE
10%
ROIC
6%
Country IT
Market Cap 6.4B EUR
ROE
18%
ROA
5%
ROCE
11%
ROIC
7%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Other Stocks